1. Home
  2. TMCI vs VHI Comparison

TMCI vs VHI Comparison

Compare TMCI & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • VHI
  • Stock Information
  • Founded
  • TMCI 2014
  • VHI 1932
  • Country
  • TMCI United States
  • VHI United States
  • Employees
  • TMCI N/A
  • VHI N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VHI Major Chemicals
  • Sector
  • TMCI Health Care
  • VHI Industrials
  • Exchange
  • TMCI Nasdaq
  • VHI Nasdaq
  • Market Cap
  • TMCI 401.8M
  • VHI 454.3M
  • IPO Year
  • TMCI 2021
  • VHI N/A
  • Fundamental
  • Price
  • TMCI $6.03
  • VHI $15.01
  • Analyst Decision
  • TMCI Hold
  • VHI Sell
  • Analyst Count
  • TMCI 5
  • VHI 1
  • Target Price
  • TMCI $8.60
  • VHI $12.00
  • AVG Volume (30 Days)
  • TMCI 292.8K
  • VHI 9.0K
  • Earning Date
  • TMCI 11-04-2025
  • VHI 11-06-2025
  • Dividend Yield
  • TMCI N/A
  • VHI 2.13%
  • EPS Growth
  • TMCI N/A
  • VHI 269.89
  • EPS
  • TMCI N/A
  • VHI 3.44
  • Revenue
  • TMCI $213,751,000.00
  • VHI $2,093,500,000.00
  • Revenue This Year
  • TMCI $10.63
  • VHI $22.20
  • Revenue Next Year
  • TMCI $9.43
  • VHI $7.66
  • P/E Ratio
  • TMCI N/A
  • VHI $4.55
  • Revenue Growth
  • TMCI 7.67
  • VHI 4.04
  • 52 Week Low
  • TMCI $4.54
  • VHI $14.10
  • 52 Week High
  • TMCI $10.79
  • VHI $41.75
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 29.93
  • VHI 34.98
  • Support Level
  • TMCI $6.09
  • VHI $15.40
  • Resistance Level
  • TMCI $6.52
  • VHI $15.92
  • Average True Range (ATR)
  • TMCI 0.31
  • VHI 0.46
  • MACD
  • TMCI -0.11
  • VHI -0.07
  • Stochastic Oscillator
  • TMCI 0.00
  • VHI 0.00

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

Share on Social Networks: